Promising anticancer activity of batumin: a natural polyene antibiotic produced by Pseudomonas batumici

Author:

Soldatkina Maria A1,Klochko Vitalii V2,Zagorodnya Svitlana D3,Rademan Sunelle4,Visagie Michelle H5,Lebelo Maphuti T5,Gwangwa Mokgadi V5,Joubert Anna M5,Lall Namrita4,Reva Oleg N6

Affiliation:

1. Department of Molecular & Cellular Pathobiology, R.E. Kavetsky Institute of Experimental Pathology, Oncology & Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine

2. Department of Antibiotics, DK Zabolotny Institute of Microbiology & Virology, National Academy of Science of Ukraine, Kyiv 03680, Ukraine

3. Department of Viruses Reproduction, DK Zabolotny Institute of Microbiology & Virology, National Academy of Science of Ukraine, Kyiv 03680, Ukraine

4. Department of Plant & Soil Sciences, Medicinal Plant Science Section, University of Pretoria, Pretoria 0002, South Africa

5. Department of Physiology, University of Pretoria, Pretoria 0001, South Africa

6. Department of Biochemistry, Genetics & Microbiology, Centre for Bioinformatics & Computational Biology, University of Pretoria, Pretoria 0002, South Africa

Abstract

Aim: To determine the computer-predicted anticancer activity of antibiotic batumin. Materials & methods: Cytotoxicity assays, cell morphology microscopy and cell cycle progression were studied in cancer and nontumorigenic cell lines. An in vivo experiment on Lewis lung carcinoma (3LL)-transplanted mice was conducted to evaluate potential antimetastatic. Results & conclusion: Cytotoxicity against melanoma and lung carcinoma cells (IC50 ≈ 5 μg/ml) was detected. Hypercondensed chromatin and apoptotic body formation in batumin-treated cells suggested the induction of apoptosis supported also by an observed increase in the quantity of cells occupying the sub-G1 cell cycle phase. Twofold reduction in the number and volume of lung metastases in Lewis lung carcinoma (3LL)-bearing batumin-treated mice was demonstrated. Highly specific cytotoxicity of batumin against cancer cell lines potentiates further studies.

Publisher

Future Science Ltd

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3